The aim of the present study was to perform a systematic review on the efficacy and safety of co-administered bedaquiline and delamanid in MDR-TB patients.
Pontali, E., Sotgiu, G., Tiberi, S., Tadolini, M., Visca, D., D'Ambrosio, L., et al. (2018). Combined treatment of drug-resistant tuberculosis with bedaquiline and delamanid: a systematic review. EUROPEAN RESPIRATORY JOURNAL, 52(1), 1-4 [10.1183/13993003.00934-2018].
Combined treatment of drug-resistant tuberculosis with bedaquiline and delamanid: a systematic review
Tadolini, Marina;
2018
Abstract
The aim of the present study was to perform a systematic review on the efficacy and safety of co-administered bedaquiline and delamanid in MDR-TB patients.File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
